Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingyu Ma

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Cancer|June 22, 2010
1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer modelsYingyu Ma, Wei-Dong Yu, Donald L Trump, et al.
Journal of Cancer Research and Clinical Oncology|September 12, 2008
The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese populationYingyu Ma, Liang Wu, Cuiping Liu, et al.
International Journal of Molecular Medicine|March 21, 2014
Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitroYaqing Li, Wulin Xu, Jianping Yan, et al.
International Journal of Clinical and Experimental Pathology|February 13, 2015
Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patientsYi Jin, Yuhui Yu, Qinshu Shao, et al.
Cancer|October 10, 2018
A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignanciesChristos Fountzilas, Milind Javle, Wei Tan, et al.
Urologic Oncology|June 28, 2014
Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinomaQi Zhang, Zhongsheng Zhao, Yingyu Ma, et al.
Oncotarget|December 15, 2016
GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancerWei Su, Shibao Li, Xiaofan Chen, et al.
Cancer Research|August 17, 2006
Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cellsYingyu Ma, Wei-Dong Yu, Rui-Xian Kong, et al.
Cancer Research|January 30, 2013
Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cellsWei Luo, Wei-Dong Yu, Yingyu Ma, et al.
Medical Oncology (Northwood, London, England)|June 8, 2014
Overexpression of Nedd9 is a prognostic marker of human gastric cancerQi Zhang, Huiju Wang, Yingyu Ma, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Cancer|June 22, 2010
1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer modelsYingyu Ma, Wei-Dong Yu, Donald L Trump, et al.
Journal of Cancer Research and Clinical Oncology|September 12, 2008
The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese populationYingyu Ma, Liang Wu, Cuiping Liu, et al.
International Journal of Molecular Medicine|March 21, 2014
Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitroYaqing Li, Wulin Xu, Jianping Yan, et al.
International Journal of Clinical and Experimental Pathology|February 13, 2015
Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patientsYi Jin, Yuhui Yu, Qinshu Shao, et al.
Cancer|October 10, 2018
A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignanciesChristos Fountzilas, Milind Javle, Wei Tan, et al.
Urologic Oncology|June 28, 2014
Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinomaQi Zhang, Zhongsheng Zhao, Yingyu Ma, et al.
Oncotarget|December 15, 2016
GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancerWei Su, Shibao Li, Xiaofan Chen, et al.
Cancer Research|August 17, 2006
Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cellsYingyu Ma, Wei-Dong Yu, Rui-Xian Kong, et al.
Cancer Research|January 30, 2013
Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cellsWei Luo, Wei-Dong Yu, Yingyu Ma, et al.
Medical Oncology (Northwood, London, England)|June 8, 2014
Overexpression of Nedd9 is a prognostic marker of human gastric cancerQi Zhang, Huiju Wang, Yingyu Ma, et al.
Pageof 6